The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Prevalence, Determinants, and Effect on Quality of Life of Freezing of Gait in Parkinson Disease
Open accessAbstract
IMPORTANCE: Freezing of gait (FOG) is a common axial symptom of Parkinson disease (PD). OBJECTIVE: To determine the prevalence of FOG in a large group of PD patients, assess its relationship with quality of life and clinical and pharmacological factors, and explore its changes from the off to on conditions in patients with motor fluctuations. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional survey of 683 patients with idiopathic PD. Scores for FOG were missing in 11 patients who were not included in the analysis. Patients were recruited from referral centers and general neurology clinics in public or private institutions in France. EXPOSURE: Patients with FOG were identified as those with a score of 1 or greater on item 14 of the Unified Parkinson's Disease Rating Scale (UPDRS) in the on condition. Item 14 scores for FOG in the off condition were also collected in patients with fluctuating motor symptoms. MAIN OUTCOMES AND MEASURES: Quality of life (measured by the 39-item Parkinson's Disease Questionnaire and 36-Item Short Form Health Survey), anxiety and depression (Hospital Anxiety and Depression Scale), clinical features (UPDRS), and drug consumption. RESULTS: Of 672 PD patients, 257 reported FOG during the onstate (38.2%), which was significantly related to lower quality of life scores (P < .01). Freezing of gait was also correlated with longer PD duration (odds ratio, 1.92 [95% CI, 1.28-2.86]), higher UPDRS parts II and III scores (4.67 [3.21-6.78]), the presence of apathy (UPDRS item 4) (1.94 [1.33-2.82]), a higher levodopa equivalent daily dose (1.63 [1.09-2.43]), and more frequent exposure to antimuscarinics (3.07 [1.35-6.97]) (logistic regression). The FOG score improved from the off to on states in 148 of 174 patients with motor fluctuations (85.1%) and showed no change in 13.8%. The FOG score improved by more than 50% in 43.7% of patients. Greater improvement in the on state was observed in younger patients (r = -0.25; P < .01) with lower UPDRS II and III scores (r = -0.50; P < .01) and no antimuscarinic use (r = -0.21; P < .01). CONCLUSIONS AND RELEVANCE: Freezing of gait in PD patients correlates with poor quality of life, disease severity, apathy, and exposure to antimuscarinics. Dopaminergic therapy improved FOG in most patients with motor fluctuations, especially younger ones with less severe disease and no antimuscarinic use. This finding suggests that quality of life is impaired in PD patients with FOG and that optimizing dopaminergic therapy and avoiding antimuscarinics should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
(1992) · PubMed · Cited by 33,716
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Self-citationMcHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
New Tables for Multiple Comparisons with a Control
Dunnett, C. W. (1964) · Biometrics · doi:10.2307/2528490 · Cited by 3,113
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Freezing of gait: moving forward on a mysterious clinical phenomenon
Nutt, J. G., Bloem, B. R., Giladi, N., Hallett, M., Horak, F. B., & Nieuwboer, A. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70143-0 · Cited by 1,304
Bloem, B. R., Hausdorff, J. M., Visser, J. E., & Giladi, N. (2004) · Movement Disorders · doi:10.1002/mds.20115 · Cited by 1,297
Parkinsonism: Onset, progression, and mortality
Hoehn, M., & Yahr, M. (2011) · Neurology · doi:10.1212/01.wnl.0000405146.06300.91 · Cited by 1,061
Freezing of gait in PD: Prospective assessment in the DATATOP cohort
Giladi, N., McDermott, M. P., Fahn, S., Przedborski, S., Jankovic, J., Stern, M., Tanner, C., & The Parkinson Study Group (2001) · Neurology · doi:10.1212/wnl.56.12.1712 · Cited by 545
Validation of the freezing of gait questionnaire in patients with Parkinson’s disease
Giladi, N., Tal, J., Azulay, T., Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W. H., Stocchi, F., & Tolosa, E. (2009) · Movement Disorders · doi:10.1002/mds.21745 · Cited by 431
Self-citationUnified Parkinson’s Disease Rating Scale
Fish, J. (2018) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-57111-9_1836 · Cited by 403
Moore, O., Peretz, C., & Giladi, N. (2007) · Movement Disorders · doi:10.1002/mds.21659 · Cited by 337
Predictors of freezing in Parkinson's disease: A survey of 6,620 patients
Macht, M., Kaussner, Y., Möller, J. C., Stiasny‐Kolster, K., Eggert, K. M., Krüger, H., & Ellgring, H. (2007) · Movement Disorders · doi:10.1002/mds.21458 · Cited by 319
Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions?
Bonnet, A.-M., Loria, Y., Saint-Hilaire, M.-H., Lhermitte, F., & Agid, Y. (1987) · Neurology · doi:10.1212/wnl.37.9.1539 · Cited by 284
JENKINSON, C., PETO, V., FITZPATRICK, R., GREENHALL, R., & HYMAN, N. (1995) · Age and Ageing · doi:10.1093/ageing/24.6.505 · Cited by 276
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
Chung, K. A., Lobb, B. M., Nutt, J. G., & Horak, F. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f6128c · Cited by 252
Han, L., Agostini, J. V., & Allore, H. G. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02009.x · Cited by 238
Shine, J. M., Matar, E., Ward, P. B., Bolitho, S. J., Gilat, M., Pearson, M., Naismith, S. L., & Lewis, S. J. G. (2013) · Brain · doi:10.1093/brain/awt049 · Cited by 227
“On” state freezing of gait in Parkinson disease: A paradoxical levodopa-induced complication
Espay, A. J., Fasano, A., van Nuenen, B. F. L., Payne, M. M., Snijders, A. H., & Bloem, B. R. (2012) · Neurology · doi:10.1212/wnl.0b013e3182477ec0 · Cited by 222
Psychosis, apathy, depression and anxiety in Parkinson's disease
Gallagher, D. A., & Schrag, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.041 · Cited by 211
The freezing phenomenon in parkinsonism.
Fahn, S. (1995) · PubMed · Cited by 177
Bartels, A. L., Balash, Y., Gurevich, T., Schaafsma, J. D., Hausdorff, J. M., & Giladi, N. (2003) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(03)00192-9 · Cited by 168
Pattern of brain tissue loss associated with freezing of gait in Parkinson disease
Kostić, V., Agosta, F., Pievani, M., Stefanova, E. D., Ječmenica‐Lukić, M., Scarale, A. F., Spica, V., & Filippi, M. (2012) · Neurology · doi:10.1212/wnl.0b013e318245d23c · Cited by 154
Medical treatment of freezing of gait
Giladi, N. (2008) · Movement Disorders · doi:10.1002/mds.21914 · Cited by 153
Freezing of gait in Parkinson’s disease
Okuma, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7007-2 · Cited by 146
Accuracy of clinical diagnosis of idiopathic Parkinson's disease.
Rajput, D. R. P. S. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.8.938 · Cited by 144
Devos, D., Defebvre, L., & Bordet, R. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00798.x · Cited by 141
The pedunculopontine nucleus as a target for deep brain stimulation
Hamani, C., Moro, E., & Lozano, A. M. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0547-8 · Cited by 88
Explaining freezing of gait in Parkinson's disease: Motor and cognitive determinants
Vercruysse, S., Devos, H., Münks, L., Spildooren, J., Vandenbossche, J., Vandenberghe, W., Nieuwboer, A., & Heremans, E. (2012) · Movement Disorders · doi:10.1002/mds.25183 · Cited by 87
Risk factors for freezing of gait in Parkinson's disease.
Contreras, A., & Grandas, F. (2012) · Journal of Neurological Sciences · doi:10.1016/j.jns.2012.06.018 · Cited by 70
Fukada, K., Endo, T., Yokoe, M., Hamasaki, T., Hazama, T., & Sakoda, S. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.031 · Cited by 52
Freezing of Gait Questionnaire: validity and reliability of the Swedish version
Nilsson, M. H., & Hagell, P. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01175.x · Cited by 37
Rasagiline in the pharmacotherapy of Parkinson’s disease – a review
Rascol, O. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.2061 · Cited by 31
Self-citationShine, J. M., Naismith, S. L., & Lewis, S. J. G. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.06.027 · Cited by 25
Cited by
Magrinelli, F., Picelli, A., Tocco, P., Federico, A., Roncari, L., Smania, N., Zanette, G., & Tamburin, S. (2016) · Parkinson's Disease · doi:10.1155/2016/9832839 · Cited by 369
Axial disability and deep brain stimulation in patients with Parkinson disease
Fasano, A., Aquino, C. C., Krauss, J. K., Honey, C. R., & Bloem, B. R. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.252 · Cited by 300
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
Bohnen, N. I., Yarnall, A. J., Weil, R. S., Moro, E., Moehle, M. S., Borghammer, P., Bedard, M.-A., & Albin, R. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00377-x · Cited by 293
A clinical view on the development of technology‐based tools in managing Parkinson's disease
Maetzler, W., Klucken, J., & Horne, M. (2016) · Movement Disorders · doi:10.1002/mds.26673 · Cited by 162
Clinicopathological characteristics of freezing of gait in autopsy‐confirmed Parkinson's disease
Virmani, T., Moskowitz, C. B., Vonsattel, J., & Fahn, S. (2015) · Movement Disorders · doi:10.1002/mds.26346 · Cited by 56
Metadata
- Authors
- Perez-Lloret, S., Negre-Pages, L., Damier, P., Delval, A., Derkinderen, P., Destée, A., Meissner, W. G., Schelosky, L., Tison, F., & Rascol, O.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-07-01
- Volume
- 71
- Issue
- 7
- Pages
- 884
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2110626075
- Cited by
- 317
- References
- 40
- FWCI
- 40.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.